Keywords: protherics, cuts, loss, readies, crofab, launch, uk
Protherics cuts loss, readies CroFAb for US launch
Article | 14 December 2000
UK biopharmaceutical company Protherics has reported turnover for theyear to September 30, 2000, up 8.4% to L490,000 ($713,587). This includes no impact from the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
